Penpulimab
Based on 1 publication(s) in Google Scholar
Penpulimab (AK105) is an anti-PD-1 monoclonal antibody that blocks PD-1/PD-L1 signaling. Penpulimab enhances T cell activation and cytokine secretion, including increased production of IL-2 and IFN-γ. Penpulimab shows in vivo antitumor activity in mouse tumor models. Penpulimab can be used in research related to metastatic nasopharyngeal carcinoma, colorectal adenocarcinoma, and relapsed or refractory classical Hodgkin lymphoma.
For research use only. We do not sell to patients.
- Purity : 98.80%
- CAS No.: 2350298-92-7
- Molecular Weight:145.14 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Penpulimab
More
Biological Activity
Description
Isotype
Human IgG1 (L234A/L235A) kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[2]|
IL-2 |
In Vitro
Penpulimab (0.1-10 μg/mL) does not trigger CDC against CHO-K1-PD1-CTLA4 cells and does not trigger obvious ADCP against CHO-K1-PD1 cells[2].
Penpulimab (3-1200 nM; co-culture for 3 days) increases IL-2 and IFN-γ production by PBMCs co-cultured with Raji-PD-L1 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human monocyte-derived macrophages and CHO-K1-PD1 cells
-
Concentration:0.05, 0.5, and 5 μg/mL
-
Incubation Time:24 h
-
Result:Did not elicit secretion of IL-6 or IL-8 by HPMMs co-cultured with PD-1-expressing cells.
-
Cell Line:Raji-PD-L1 cells and human PBMCs
-
Concentration:3, 30, 300, 600, 900, and 1200 nM
-
Incubation Time:3 days
-
Result:Significantly increased IL-2 and IFN-γ production by PBMCs co-cultured with Raji-PD-L1 cells.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Flow cytometric analysis of 1X106 10 ng/mL PMA and 1 μg/mL Ionomycin co-stimulated Jurkat cells(24h) with Penpulimab (HY-P99108, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Fluor 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Chemical Information
-
CAS No. 2350298-92-7
-
Appearance Liquid
-
Molecular Weight 145.14 kDa
-
Color Colorless to light yellow
-
SMILES
[Penpulimab]
-
Synonyms
AK105
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Purity & Documentation
-
Data Sheet (279 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)